Literature DB >> 17990842

Pharmacogenetics: using DNA to optimize drug therapy.

David E Lanfear1, Howard L McLeod.   

Abstract

Pharmacogenetics is a growing field of research that focuses on the interaction between genetics and drug therapy. Relationships between genetic variation and drug effect have been observed for a growing number of commonly used drugs. Validation studies may soon define the use of these relationships in clinical practice, moving the field toward routine application. Currently, there are only a few pharmacogenetic diagnostic tests available, and clinical guidelines for pharmacogenetically tailored therapy are lacking. It is likely that guidelines for pharmacogenetic dosing of certain commonly used drugs such as warfarin, codeine, and inhaled beta agonists will become available within the next few years.

Entities:  

Mesh:

Year:  2007        PMID: 17990842

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  8 in total

1.  Alternative reliable method for cytochrome P450 2D6 poor metabolizers genotyping.

Authors:  E Pindurová; A Zourková; J Zrůstová; J Juřica; A Pavelka
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

Review 2.  Progress toward genetic tailoring of heart failure therapy.

Authors:  John H Lillvis; David E Lanfear
Journal:  Curr Opin Mol Ther       Date:  2010-06

Review 3.  Pharmacogenetics in chronic heart failure: new developments and current challenges.

Authors:  Jasmine A Talameh; David E Lanfear
Journal:  Curr Heart Fail Rep       Date:  2012-03

Review 4.  Genetic variation in the natriuretic peptide system and heart failure.

Authors:  David E Lanfear
Journal:  Heart Fail Rev       Date:  2008-10-11       Impact factor: 4.214

5.  Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory strain diversity panel.

Authors:  Alison H Harrill; Pamela K Ross; Daniel M Gatti; David W Threadgill; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2009-05-06       Impact factor: 4.849

6.  Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans.

Authors:  Alison H Harrill; Paul B Watkins; Stephen Su; Pamela K Ross; David E Harbourt; Ioannis M Stylianou; Gary A Boorman; Mark W Russo; Richard S Sackler; Stephen C Harris; Philip C Smith; Raymond Tennant; Molly Bogue; Kenneth Paigen; Christopher Harris; Tanupriya Contractor; Timothy Wiltshire; Ivan Rusyn; David W Threadgill
Journal:  Genome Res       Date:  2009-05-05       Impact factor: 9.043

Review 7.  Theranostics: A treasured tailor for tomorrow.

Authors:  S Jeelani; R C Jagat Reddy; Thangadurai Maheswaran; G S Asokan; A Dany; B Anand
Journal:  J Pharm Bioallied Sci       Date:  2014-07

8.  Sex as a Prognostic Factor in Systematic Reviews: Challenges and Lessons Learned.

Authors:  Elena Stallings; Alba Antequera; Jesús López-Alcalde; Miguel García-Martín; Gerard Urrútia; Javier Zamora
Journal:  J Pers Med       Date:  2021-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.